Hossein Borghaei, Luis G. Paz-Ares, Martin Reck, Roy S. Herbst, Solange Peters, Kamalnayan Bhatt, Xiaoyan Wang, Jonathon Gable, Siobhán Connor-Ahmad, Carla Mamolo, Ya-Chen Lin, Stephen V. Liu. "IMforte: Quality-adjusted time without symptoms or toxicity (Q-TWiST) analysis of first-line maintenance (1Lm) treatment (Tx) with lurbinectedin (lurbi) + atezolizumab (atezo) vs atezo in extensive-stage small cell lung cancer (ES-SCLC).." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.8086